Astellas Pharma joined PPMD for a webinar on May 19, 2021 to provide an update on the company’s ASP0367 development program. Research & Clinical Trial Webinars,Webinars 4 years ago You may also like 44:01 World Muscle Society 2024: CIFFREO Data Discussion with Pfizer 9 months ago Research & Clinical Trial Webinars,Webinars fordadistrogene movaparvovec,pfizer 59:49 Webinar: SHIELD DMD – A Bone Health Study in Duchenne 9 months ago Research & Clinical Trial Webinars,Webinars satralizumab 43:40 Webinar: Interim Results from FORWARD-53 Study of WVE-N531 in Duchenne Muscular Dystrophy 9 months ago Research & Clinical Trial Webinars,Webinars wave life sciences,WVE-N531 51:42 Webinar: Overview of DUVYZAT and Access Resources (September 2024) 10 months ago Research & Clinical Trial Webinars,Webinars 1:04:54 Webinar: Advocating for A Successful School Year (September 2024) 10 months ago Care Webinars,Webinars 1:01:24 Webinar: PPMD Advocacy – Raising Our Voices in 2024 and Beyond [Sep 2024] 10 months ago Webinars 1:00:59 Webinar: Advancing DYNE-251 – An Investigational Medicine for Duchenne to Deliver for Patients 11 months ago Research & Clinical Trial Webinars,Webinars dyne therapeutics,DYNE-251 1:05:32 Webinar: Edgewise Therapeutics – Clinical Trials in Becker Muscular Dystrophy 11 months ago Research & Clinical Trial Webinars,Webinars edgewise «12345…27»Page 3 of 27